Evidence map›Paper›PMID 21398610›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.

Tâm D Quách, Nataly Manjarrez-Orduño, Diana G Adlowitz, Lin Silver, Hongmei Yang, Chungwen Wei, Eric C B Milner, Iñaki Sanz

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 132 citations in OpenAlex.

  1. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. IgDPathogens (Basel, Switzerland) · 2024
    Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tâm D QuáchDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Nataly Manjarrez-Orduño
Diana G Adlowitz
Lin Silver
Hongmei Yang
Chungwen Wei
Eric C B Milner
Iñaki Sanz
University of Rochester · US

Funding

Translational Research Project Effector and Regulatory B cells in SLEU19AI056390 · NIAID · UNIVERSITY OF ROCHESTER · PI MOSMANN, TIM R. · 2003 to 2013
$8.9M
TRAINING PROGRAM IN ORAL SCIENCET32DE007202 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 1990 to 2010
$5.5M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
A Model System for the Study of Human B-cell ToleranceR01AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2003 to 2007
$1.6M
A Model System for the Study of Human B-cell ToleranceR56AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2009 to 2009
$385k
NIAID NIH HHS R01 AI049660NIAID NIH HHS R37 AI049660NIAID NIH HHS R56 AI049660NIAID NIH HHS U19 AI056390NIAID NIH HHS U19 AI49660NIDCR NIH HHS T32 DE007202NIDCR NIH HHS T32-DE007202
6 · The paper itself

Abstract

B cell anergy represents an important mechanism of peripheral immunological tolerance for mature autoreactive B cells that escape central tolerance enforced by receptor editing and clonal deletion. Although well documented in mice, the extent of its participation in human B cell tolerance remains to be fully established. In this study, we characterize the functional behavior of strictly defined human naive B cells separated on the basis of their surface IgM (sIgM) expression levels. We demonstrate that cells with lower sIgM levels (IgM(lo)) are impaired in their ability to flux calcium in response to either anti-IgM or anti-IgD cross-linking and contain a significantly increased frequency of autoreactive cells compared with naive B cells with higher levels of sIgM. Phenotypically, in healthy subjects, IgM(lo) cells are characterized by the absence of activation markers, reduction of costimulatory molecules (CD19 and CD21), and increased levels of inhibitory CD22. Functionally, IgM(lo) cells display significantly weaker proliferation, impaired differentiation, and poor Ab production. In aggregate, the data indicate that hyporesponsiveness to BCR cross-linking associated with sIgM downregulation is present in a much larger fraction of all human naive B cells than previously reported and is likely to reflect a state of anergy induced by chronic autoantigen stimulation. Finally, our results indicate that in systemic lupus erythematosus patients, naive IgM(lo) cells display increased levels of CD95 and decreased levels of CD22, a phenotype consistent with enhanced activation of autoreactive naive B cells in this autoimmune disease.

Indexed as

Antibodies, Anti-IdiotypicAntigens, CD19AutoantigensB-LymphocytesCalciumCell MembraneCells, CulturedClonal Anergyfas ReceptorFlow CytometryHumansImmunoglobulin DImmunoglobulin MIon TransportLupus Erythematosus, SystemicReceptors, Complement 3dAntibodies, Anti-IdiotypicAntigens, CD19anti-IgDanti-IgMAutoantigensCalciumfas ReceptorImmunoglobulin DImmunoglobulin MReceptors, Complement 3dSialic Acid Binding Ig-like Lectin 2

Identifiers

PMID21398610
PMCPMC3095097
OpenAlexW1686167184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.